4
Changes in Ownership
FENNEC PHARMACEUTICALS INC. Filed Acc 0001468308-26-000012
CHIEF FINANCIAL OFFICER acquired 29,735 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Andrade Robert · CHIEF FINANCIAL OFFICER
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-02-18 | Exercise or conversion : show line 1 in the form | +2,450 | $4.08 | $9,996 | 215,108 | D |
| 2026-02-18 | Exercise or conversion : show line 2 in the form | +27,285 | 242,393 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-02-18 | Exercise or conversion : show line 3 in the form Stock Options | −2,450 | $4.08 | $9,996 | 814,117 | D |
Loading xslF345X05/form4-02192026_110240.xml…